CoinShares Reports $217M Inflows into Digital Asset Investment Products Last Week

iconKuCoinFlash
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy
AI summary iconSummary

expand icon
CoinShares reported $21.7 billion in inflows into digital asset investment products last week, the largest weekly inflow since October 2025. Bitcoin led with $15.5 billion in ETF inflows, Ethereum with $496 million, and Solana with $45.5 million. Blockchain stocks also saw $72.6 million in inflows. XRP and Sui added $69.5 million and $5.7 million, respectively. The U.S. accounted for $2.05 billion, followed by Germany and Switzerland. Inflows remained strong despite the proposed CLARITY Act restrictions on stablecoin yield features.

BlockBeats news: On January 19, CoinShares released its latest weekly report, stating that digital asset investment products recorded a net inflow of $217 million last week, the largest weekly inflow since October 2025. Bitcoin led the way, attracting $155 million in investments, while Ethereum and Solana received $49.6 million and $4.55 million, respectively. Blockchain stocks also performed strongly, drawing in $72.6 million in investments.


Although the CLARITY Act proposed by the U.S. Senate Banking Committee may restrict stablecoin yield features, multiple altcoins still recorded inflows of funds, including XRP ($69.5 million) and Sui ($57 million). The majority of the capital inflows came from the United States ($2.05 billion), followed by regions such as Germany and Switzerland.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.